Review: taking Trileptal and Aricept together


Summary

Drug interactions are reported among people who take Trileptal and Aricept together. This review analyzes the effectiveness and drug interactions between Trileptal and Aricept. It is created by eHealthMe based on reports of 94 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Trileptal

Trileptal has active ingredients of oxcarbazepine. It is often used in epilepsy. (latest outcomes from Trileptal 15,601 users)

Aricept

Aricept has active ingredients of donepezil hydrochloride. It is often used in dementia alzheimer's type. (latest outcomes from Aricept 18,538 users)

On Sep, 14, 2016

94 people who take Trileptal, Aricept are studied.


Number of reports submitted per year:

Trileptal and Aricept drug interactions.

Drug effectiveness over time:

Trileptal:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)
Aricept:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 0.0% - (0 of 0 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Trileptal:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)
Aricept:
  • female: 0.0% - (0 of 0 people)
  • male: 0.0% - (0 of 1 people)

Drug effectiveness by age:

Trileptal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)
Aricept:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 0.0% - (0 of 0 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 0.0% - (0 of 1 people)

Most common drug interactions over time *:

< 1 month:
  • dysgeusia
  • gait disturbance
  • herpes zoster
  • abnormal behaviour
  • ageusia
  • ataxia
  • convulsion
  • diarrhoea
  • dizziness
  • drug toxicity
2 - 5 years:
  • depression
  • gastrooesophageal reflux disease
  • hyperhidrosis
not specified:
  • fall
  • asthenia
  • renal disorder
  • weight increased
  • diarrhoea
  • dyspnoea
  • multiple sclerosis
  • urinary tract infection
  • gait disturbance
  • nausea

Most common drug interactions by gender *:

female:
  • fall
  • asthenia
  • diarrhoea
  • dyspnoea
  • multiple sclerosis
  • nausea
  • renal disorder
  • influenza
  • urinary tract infection
  • weight increased
male:
  • diabetes mellitus
  • drug effect decreased
  • prostate cancer
  • somnolence
  • urinary tract infection staphylococcal
  • abdominal wall haemorrhage
  • cerebral atrophy
  • confusional state
  • cough
  • death

Most common drug interactions by age *:

20-29:
  • convulsion
  • injection site pain
  • injection site swelling
  • leukaemia
  • seizure
30-39:
  • diabetes mellitus
  • cerebral atrophy
  • somnolence
  • tooth impacted
  • weight increased
  • confusional state
  • deep vein thrombosis
  • libido decreased
  • migraine
  • psychotic disorder
40-49:
  • sedation
  • abnormal behaviour
  • alcohol problem
  • ataxia
  • cardiac disorder
  • cholelithiasis
  • diabetes mellitus
  • drug toxicity
  • glycosylated haemoglobin increased
  • hepatic steatosis
50-59:
  • influenza
  • abdominal pain lower
  • atelectasis
  • cardiomegaly
  • diarrhoea
  • gastrointestinal disorder
  • injection site haematoma
  • injection site inflammation
  • renal disorder
  • upper respiratory tract infection
60+:
  • fall
  • asthenia
  • drug effect decreased
  • haemorrhagic anaemia
  • multiple sclerosis
  • prostate cancer
  • urinary tract infection
  • urinary tract infection staphylococcal
  • gait disturbance
  • abdominal wall haemorrhage

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Trileptal and Aricept?

Can you answer these questions?

More questions for: Trileptal, Aricept

You may be interested in these reviews

More reviews for: Trileptal, Aricept

On eHealthMe, Trileptal (oxcarbazepine) is often used to treat epilepsy. Aricept (donepezil hydrochloride) is often used to treat dementia alzheimer's type. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.